We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Sugar Plays Greater Role in Heart Disease Than Saturated Fats

By HospiMedica International staff writers
Posted on 24 Jan 2016
A new study claims that the effect of consuming a diet high in sugar on atherosclerotic coronary heart disease (CHD) is more detrimental than that of saturated fat.

Researchers at Saint Luke's Mid America Heart Institute (Kansas City, MO, USA) and Albert Einstein College of Medicine (New York, NY, USA) reviewed the evidence to date linking saturated fats and sugars to CHD, and concluded that while dietary guidelines continue to recommend restricting intake of saturated fats, this recommendation follows largely from the observation that saturated fats can raise levels of total serum cholesterol, thereby putatively increasing the risk of atherosclerotic CHD. More...


However, they claim, total serum cholesterol is only modestly associated with CHD, and more important than the total level of cholesterol in the blood may be the number and size of low-density lipoprotein (LDL) particles that it contains. Different saturated fats may have different effects on LDL and on broader CHD risk, based on the specific saturated fatty acids (SFAs) they contain. And since people eat foods, not isolated fatty acids, some sources of SFAs may pose no risk for CHD, or possibly even be protective.

As such, advice to reduce saturated fat in the diet without regard to nuances about LDL, SFAs, or dietary sources could actually increase people's risk of CHD. In particular, when saturated fats are replaced with refined carbohydrates, changes in LDL, high-density lipoprotein (HDL), and triglycerides may increase the risk of CHD. Additionally, diets high in sugar may induce other abnormalities associated with higher CHD risk, including elevated levels of glucose, insulin, and uric acid, impaired glucose tolerance, insulin and leptin resistance, non-alcoholic fatty liver disease, and altered platelet function.

The researchers also found that a diet high in added sugars can cause a 3-fold increased risk of death due to cardiovascular disease (CVD). But sugars, like saturated fats, are a diverse class of compounds; monosaccharide, fructose, and fructose-containing sweeteners (such as sucrose) produce greater degrees of metabolic abnormalities than does glucose, and may present greater risk of CHD. The researchers therefor concluded that sugar consumption, particularly in the form of refined added sugars, are a greater contributor to CHD than saturated fats.

They therefore recommend that dietary guidelines should shift focus away from reducing saturated fat and replacing saturated fat with carbohydrates, specifically when these carbohydrates are refined. To reduce the burden of CHD, guidelines should focus particularly on reducing intake of concentrated sugars, specifically the fructose-containing sugars like sucrose and high-fructose corn syrup in the form of ultra-processed foods and beverages. The study was published in the January 2016 issue of Progress in Cardiovascular Diseases.

“After a thorough analysis of the evidence it seems appropriate to recommend dietary guidelines shift focus away from recommendations to reduce saturated fat and towards recommendations to avoid added sugars,” said study coauthor James DiNicolantonio, PharmD, of Saint Luke's. “Most importantly, recommendations should support the eating of whole foods whenever possible and the avoidance of ultra-processed food.”

Related Links:

Saint Luke's Mid America Heart Institute
Albert Einstein College of Medicine



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Syringes
Prefilled Saline Flush Syringes
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.